JEFFREY HILBURN: Open Payments
NPI 1871536458 · WESTMINSTER, CO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$785 in 44 payments from 16 companies in 2025. Trend: 2023 $934 · 2024 $808 · 2025 $785
Food & beverage: $785
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 15 | $232 |
| GlaxoSmithKline, LLC. | 4 | $74 |
| PFIZER INC. | 3 | $65 |
| Bayer Healthcare Pharmaceuticals Inc. | 3 | $56 |
| Astellas Pharma US Inc | 3 | $55 |
| Amgen Inc. | 2 | $47 |
| Lilly USA, LLC | 2 | $42 |
| Novo Nordisk Inc | 2 | $37 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $35 |
| AstraZeneca Pharmaceuticals LP | 2 | $33 |
Products named: VRAYLAR, NURTEC ODT, JARDIANCE, Kerendia, Veozah, TRELEGY ELLIPTA, AREXVY, Ozempic.
Industry payments across CO — which companies pay providers there.
